Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers
NCT00154726
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Locally Advanced and Recurrent/Metastatic Gastric Cancer
Interventions
DRUG:
Paclitaxel-HDFL
Sponsor
National Taiwan University Hospital